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The caspase recruitment domain (CARD) is present in death-
domain superfamily proteins involved in inflammation and
apoptosis. BinCARD is named for its ability to interact with
Bcl10 and inhibit downstream signalling. Human BinCARD is
expressed as two isoforms that encode the same N-terminal
CARD region but which differ considerably in their C-termini.
Both isoforms are expressed in immune cells, although
BinCARD-2 is much more highly expressed. Crystals of the
CARD fold common to both had low symmetry (space group
P1). Molecular replacement was unsuccessful in this low-
symmetry space group and, as the construct contains no
methionines, first one and then two residues were engineered
to methionine for MAD phasing. The double-methionine
variant was produced as a selenomethionine derivative, which
was crystallized and the structure was solved using data
measured at two wavelengths. The crystal structures of the
native and selenomethionine double mutant were refined to
high resolution (1.58 and 1.40 A˚ resolution, respectively),
revealing the presence of a cis-peptide bond between Tyr39
and Pro40. Unexpectedly, the native crystal structure revealed
that all three cysteines were oxidized. The mitochondrial
localization of BinCARD-2 and the susceptibility of its
CARD region to redox modification points to the intriguing
possibility of a redox-regulatory role.
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1. Introduction
Proteins containing a caspase recruitment domain (CARD)
are members of the death-domain superfamily that share a six-
-helix bundle topology. This superfamily includes members
of the death-domain, the death-effector domain and the pyrin-
domain families, each of which has important regulatory roles
in the immune response and apoptosis (Kersse et al., 2011).
Bcl10-interacting CARD (BinCARD) is a predicted CARD
protein. According to the UniProt knowledgebase (http://
www.uniprot.org) the mouse genome encodes one BinCARD
isoform, whereas the human gene (C9orf89) generates two
alternative splice isoforms: BinCARD-1 and BinCARD-2.
BinCARD-1 is likely to be a consequence of intron retention
(Fig. 1a). Both isoforms are identical in sequence up to residue
101, which includes the CARD fold, but bear no resemblance
to each other thereafter (Fig. 1b).
BinCARD-1 has an additional 127 C-terminal residues and
has been reported to bind to Bcl10, a cytoplasmic CARD
protein that regulates the function of immune cells including
macrophages, T cells and B cells (Thome & Tschopp, 2002). A
major role of Bcl10 is the activation of the nuclear factor-B
(NF-B) transcription factor through
CARD–CARD interactions (Ruland et
al., 2001). Unusually, the interaction of
BinCARD-1 with Bcl-10 inhibits the
NF-B pathway (Woo et al., 2004).
BinCARD-2 is the REFSEQ form
(Pruitt et al., 2009) and has an additional
82 C-terminal residues after the CARD,
including a predicted 20-residue trans-
membrane domain.
We are interested in the structure and
function of proteins that play a role in
immunity (Puri et al., 2006). Microarray
experiments suggested that BinCARD
mRNA was highly expressed in mouse
macrophages. To confirm the relative
levels of expression of the two human
BinCARD splice isoforms in immune
cells, we performed real-time quantita-
tive polymerase chain reaction analysis
of mononuclear and polymorpho-
nuclear immune-cell subsets. These data
showed that both human BinCARD
isoforms are widely expressed among
these cells, but were most highly
expressed in myeloid cells (poly-
morphonuclear granulocytes, CD14+
monocytes, monocyte-derived macro-
phages and dendritic cells) in compar-
ison to CD3+ T cells, CD19+ B cells and
CD56+ NK/NKT cells (Supplementary
Fig. S1A1). In all peripheral blood cell fractions BinCARD-2
appears to be the dominantly expressed isoform. We therefore
set out to characterize the structure of human BinCARD.
2. Materials and methods
2.1. Summary of BinCARD constructs used
BinCARD-1 (full-length human BinCARD isoform 1),
BinCARD-2 (full-length human BinCARD isoform 2),
BinCARD-N (residues 1–100 common to both isoforms) and
BinCARD-CARD (residues 3–101 common to both isoforms)
were used to generate crystals; BinCARD-2-124–183 (resi-
dues 2–123 of isoform 2) gave a soluble form of the protein for
in vitro studies of oligomeric state.
2.2. Oligomeric state
Multi-angle laser light scattering (MALLS) was performed
by injecting 100 ml BinCARD-2-124–183 at 5 mg ml1 onto
a Superdex 75 10/300 GL column (GE Healthcare) equili-
brated with 25 mMHEPES pH 7.5, 150 mMNaCl, 2 mMDTT.
The molecular weight was measured using a DAWNHELEOS
II laser-light detector connected to an Optilab refractive-index
detector (Wyatt Technology). All calculations were performed
with the ASTRA software (Wyatt Technology).
2.3. Recombinant protein production
BinCARD-CARD (residues 3–101) and BinCARD-2-
124–183 (residues 2–123 of BinCARD isoform 2) were
amplified from a gene encoding full-length human BinCARD-
2 (Open Biosystems). The amplified gene product was ligated
into the N-terminal His-tag pMCSG7 vector using ligation-
independent cloning (Stols et al., 2002). This vector was
transformed into Escherichia coli BL21(DE3)pLysS cells and
expressed at 298 K for 24 h by autoinduction (Studier, 2005).
A cell pellet from a 1 l culture was lysed in 150 ml 50 mM
HEPES pH 7.5, 300 mMNaCl, 5 mMMgCl2, 1% Triton X-100,
25 mg ml1 DNase (Sigma–Aldrich), 100 ml protease-inhibitor
cocktail III (AG Scientific Inc.). Supernatant from the cell
lysate was incubated with 5 ml TALON cobalt resin (Clon-
tech) for 2 h with rotation. The resin was washed with 100 ml
wash buffer consisting of 50 mM HEPES pH 7.5, 300 mM
NaCl, 20 mM imidazole. The His-tagged CARD of BinCARD
was eluted from the resin with elution buffer consisting of
50 mM HEPES pH 7.5, 300 mM NaCl, 300 mM imidazole.
The His tag was removed by adding 1 mg tobacco etch virus
(TEV) protease per 100 mg of eluted protein. The mixture
was dialysed for 48 h in 3500 Da molecular-weight cutoff
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Figure 1
Splice variants of human BinCARD. (a) The two human BinCARD isoforms share identical exons
1–3. The longer isoform, BinCARD-1, is a consequence of the extension of exon 3. The shorter
isoform, BinCARD-2, consists of six short exon sequences. The genomic sequence information is
from the Ensembl genome database. (b) Sequence alignment of the two human BinCARD protein
isoforms. Residue numbers correspond to the full-length proteins. Conserved residues are shown in
red and the predicted transmembrane helix of BinCARD-2 is highlighted in grey. Residues 1–101
are the same for the two isoforms. This sequence alignment was generated using ClustalW from
Network Protein Sequence Analysis using default parameters (Combet et al., 2000).
1 Supplementary material has been deposited in the IUCr electronic archive
(Reference: TZ5022). Services for accessing this material are described at the
back of the journal.
membrane tubing (Pacific Lab) against 2 l 50 mM HEPES,
300 mM NaCl, 2 mM fresh DTT at 277 K. After dialysis,
cleaved and uncleaved proteins were separated using TALON
cobalt metal-affinity resin (Clontech). The flowthrough
containing the His-tag-cleaved protein was collected and was
further purified by size-exclusion chromatography (SEC) on a
Superdex 75 16/60 column (GE Healthcare) equilibrated with
SEC buffer consisting of 25 mM HEPES pH 7.5, 150 mM
NaCl, 2 mM fresh DTT.
The F16M/L66M double mutant of BinCARD-CARD was
engineered for crystal structure phasing purposes and was
produced using the QuikChange site-directed mutagenesis
protocol (Stratagene). Seleno-dl-methionine (SeMet)
labelled BinCARD-CARD double mutant was produced
using a previously described method (Edeling et al., 2001) by
transforming the variant into E. coli BL21(DE3) cells and
expressing it in minimal medium containing 100 mg SeMet per
litre of culture at 298 K with IPTG induction. Purification of
the SeMet-BinCARD double mutant followed the same
procedure as used for the native protein.
2.4. Crystallization and data collection
Crystals of native BinCARD-CARD grew in two different
conditions from hanging-drop vapour-diffusion experiments
performed at room temperature using 32 mg ml1 protein.
The first condition consisted of 50 mM HEPES pH 7.0,
100 mM ammonium sulfate, 5% DMSO, 15% PEG 8000 and
1 mM each of reduced and oxidized l-glutathione. The second
condition consisted of 100 mM bis-tris pH 6.5, 200 mM
ammonium sulfate, 25% PEG 3350. The best crystals of native
BinCARD-CARD were obtained by streak-seeding crystals
grown in the first condition at 32 mg ml1 protein into the
same condition prepared with protein at 8 mg ml1. For
SeMet-BinCARD, the best crystals were obtained using the
second condition with streak-seeding. Prior to data collection,
both native and SeMet-labelled crystals were soaked in well
solutions augmented with cryoprotectants consisting of 15%
and 10% PEG 400, respectively. The crystals were then flash-
cooled in liquid nitrogen.
X-ray diffraction data were measured on the MX2 beamline
at the Australian Synchrotron at 100 K using the Blu-Ice
software (McPhillips et al., 2002). The presence of a selenium
signal in the SeMet crystal was confirmed by a fluorescence
excitation scan at a wavelength of 0.9537 A˚. A total of 1080 of
diffraction data were measured at each of two wavelengths
(remote, 0.9537 A˚; inflection, 0.9797 A˚). Data were indexed
and integrated by XDS (Kabsch, 2010) and scaled using
SCALA (Winn et al., 2011).
2.5. Structure determination
Heavy-atom position determination and initial model
building were carried out by SHELXC/D/E (Sheldrick, 2010)
and autoSHARP (Vonrhein et al., 2007). Structure refinement
was performed using PHENIX (Adams et al., 2010). The
B-factor model used for both the native and SeMet mutant
structures was isotropic. H atoms (riding model) and water
molecules were added automatically during refinement in
PHENIX. Several rounds of refinement were performed with
manual rebuilding in Coot (Emsley & Cowtan, 2004), followed
by further refinement in PHENIX. The quality and geometry
of the refined structures were evaluated byMolProbity (Chen
et al., 2010). Residue Cys63 was modelled as a cysteine sulfenic
acid (CSO) in the two molecules in the asymmetric unit. The
electron density for CSO63 also suggested an alternative
conformation. The final model of the native structure
contained 96 residues and 153 water molecules. Residues Ser3,
Asn2 and Ala1 at the N-terminus and Ala100 and Leu101 at
the C-terminus were disordered, and were not included in the
final model. Structure figures were produced using PyMOL
and structure comparisons were performed using DALI
(Holm & Rosenstro¨m, 2010). The coordinates and structure
factors have been deposited in the Protein Data Bank with
PDB codes 4dwn and 4fh0 for the native and SeMet-labelled
protein, respectively.
2.6. Antibodies and constructs for mammalian cell expression
The polyclonal anti-HA (H6908) antibody was obtained
from Sigma–Aldrich. The anti-V5 monoclonal antibody
(MCA1360) was obtained from AbD Serotec and rabbit
monoclonal anti-Bcl-xL (54H6) was obtained from Cell
Signalling Technology. Fluorescent secondary antibodies
(Alexa 488-conjugated and Alexa 594-conjugated) were
obtained from Molecular Probes.
The expression construct for ICMT-GFP (Dai et al., 1998)
has been described previously. For mammalian cell expression,
human isoforms BinCARD-1 and BinCARD-2 were amplified
from human monocyte-derived macrophage cDNA and
cloned into pEF6/V5-HisTOPO (Invitrogen) in frame with a
C-terminal V5 and His tag. The CARD region of BinCARD
(BinCARD-N) consisting of residues 1–100 (identical in
BinCARD-1 and BinCARD-2) was amplified using the
primers 50-ACCATGACAGATCAGACCTATTGTGACC-30
(sense) and 50-AGCGTGGCGGCTGGGCAGG-30 (antisense)
and similarly cloned into the same expression vector.
2.7. Peripheral blood mononuclear cell fractionation and
real-time qPCR
Fresh peripheral blood was fractionated into polymorpho-
nuclear, mononuclear and erythrocyte fractions using a double
Histopaque 1119/1077 gradient (Sigma). CD14+ monocytes,
CD4+ T cells, CD19+ B cells and CD56+ natural killer (NK)
and NKT cells were purified from the mononuclear fraction
according to standard protocols (Miltenyi Biotec). Human
monocyte-derived dendritic cells (HMDCs) and human
monocyte-derived macrophages (HMDMs) were differ-
entiated for 7 d with GM-CSF (100 ng ml1) plus IL-4
(25 ng ml1) or M-CSF (100 ng ml1), respectively (all from
Immunotools). The preparations of CD14+ and CD3+ cells
were 97–99% pure, while the less abundant cell types were
enriched (55% CD19+ B cells, 70% CD56+ NK and NKT
cells). Isolation of total RNA from individual cell populations
and subsequent cDNA synthesis and analysis by real-time
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qPCR were performed as described previously (Schroder et
al., 2012). Specific primers were used for BinCARD-1
[50-GCCCGTTGACTAACTATGCTCT-30 (forward) and
50-GGCAGCAGGGAGGTGTTAC-30 (reverse)] and BinCARD-2
[50-GACTGCCAGGAGTTCTACCG-30 (forward) and 50-
CATGGGTCCCCTGTTACTCA-30 (reverse)]. BinCARD
expression levels were normalized to the housekeeping gene
hypoxanthine guanine phosphoribosyl transferase (HPRT).
2.8. Cell culture and transfection
All cell-culture reagents were obtained from Invitrogen.
HeLa cells were maintained in DMEM (25 mM glucose)
supplemented with 10% foetal bovine serum, 2 mM
GlutaMAX I and non-essential amino acids and were trans-
fected using Lipofectamine and Plus Reagent according to the
manufacturer’s protocols. Briefly, cells were seeded at 40–50%
confluence onto glass coverslips in a 24-well plate for 24 h.
The wells were washed in OptiMEM reduced serum medium
containing 2 mM GlutaMAX I. A transfection mixture
consisting of 0.25 mg DNA and 1 ml Plus
Reagent in 50 ml OptiMEM (per well)
was prepared and allowed to incubate
for 5 min at room temperature before
combining with 1 ml Lipofectamine. The
mixture was incubated for 25 min at
room temperature to allow lipid-
complex formation before being added
to the prepared cells. The medium was
replaced with complete culture medium
after 3 h and the cells were fixed after
18–21 h.
2.9. Immunofluorescence microscopy
Cells were fixed and processed for
immunofluorescence microscopy as
described previously (Richards et al.,
2002) with the following exceptions:
fixation in 4% paraformaldehyde was
followed by permeabilization in 0.1%
Triton X-100 in phosphate-buffered
saline (PBS) (except when labelling
with anti-Bcl-xL, when a 5 min methanol
treatment at 253 K was used) and the
blocking solution was 0.5% bovine
serum albumin in PBS. Experiments
were viewed and imaged using either a
Zeiss Axioplan 2 epifluorescent micro-
scope or a Zeiss LSM 510 META
confocal microscope.
2.10. Subcellular fractionation and
Western blotting
HeLa cells transiently transfected
with BinCARD-2 were fractionated as
described previously (Whitehead et al.,
2001). Equal protein loads of the
various fractions were analyzed by SDS–PAGE and Western
blotting as described elsewhere (Richards et al., 2006).
3. Results
3.1. BinCARD-CARD is monomeric
We screened several constructs of human BinCARD using
a small-scale parallel processing approach that allowed us to
rapidly identify which of these constructs could be produced
in a soluble form (Puri et al., 2006). Two constructs met these
criteria: BinCARD-CARD (residues 3–101, corresponding to
the CARD fold common to both human BinCARD isoforms)
and BinCARD-2-124–183 (equivalent to human BinCARD-
2 residues 1–123 and lacking the transmembrane domain and
C-terminal residues).
CARD proteins are thought to self-associate (Shiozaki et
al., 2002; Park et al., 2007; Scott et al., 2009), so we first tested
whether either of these constructs could homo-oligomerize in
solution. However, both proteins eluted as a single peak on
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Table 1
Data-processing, phasing and refinement statistics.
Values in parentheses are for the highest resolution shell.
SeMet-labelled (F16M, L66M)
Native Remote Inflection point
Space group P1 P1 P1
Wavelength (A˚) 0.9537 0.9537 0.9797
Resolution (A˚) 41.11–1.57 (1.64–1.57) 40.7–1.40 (1.50–1.40) 40.67–1.40 (1.47–1.40)
Unit-cell parameters (A˚, ) a = 32.1, b = 36.5,
c = 43.8,  = 71.5,
 = 90.3,  = 68.9
a = 32.2, b = 36.7,
c = 43.7,  = 108.5,
 = 90.3,  = 111.0
a = 32.2, b = 36.6,
c = 43.3,  = 108.5,
 = 90.3,  = 110.9
Total observations 91718 236909 234284
Unique reflections 23456 32997 32797
Completeness (%) 96.4 (90.6) 96.5 (93.3) 95.8 (92.4)
Rmerge† 0.052 (0.34) 0.06 (0.28) 0.08 (0.58)
hI/(I)i 25.8 (3.73) 22.0 (7.5) 16.2 (4.4)
Multiplicity 3.9 (3.6) 7.2 (7.3) 7.1 (7.0)
Phasing statistics
No. of selenium sites
expected/found
4/4
Overall CC‡ 0.691
Overall FOM‡ 0.482
Refinement statistics
Resolution (A˚) 29.66–1.58 (1.64–1.58) 27.72–1.40 (1.44–1.40)
Rwork/Rfree§ 0.163/0.199 0.137/0.177
No. of protein atoms
(not including H)
1648 1647
No. of waters 154 206
No. of other atoms (sulfate) 3 3
Wilson B factor (A˚2) 18 12
Average B factor} (A˚2)
Protein 24.8 17.0
Water 31.1 28.7
Sulfate 37.5 27.9
R.m.s. deviations
Bond lengths (A˚) 0.013 0.010
Bond angles () 1.4 1.3
Ramachandran plot†† (%)
Favoured 97.9 98.4
Outliers 0.0 0.0
† Rmerge =
P
hkl
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ, where Ii(hkl) is the ith observation of the intensity of the
reflection hkl. ‡ Calculated using autoSHARP (Vonrhein et al., 2007). § Rwork =
P
hkl

jFobsj  jFcalcj

=
P
hkl jFobsj,
where Fobs and Fcalc are the observed and calculated structure-factor amplitudes for each reflection hkl. Rfree was
calculated with 5% of the diffraction data that were selected randomly and excluded from refinement. } Calculated
using BAVERAGE (Winn et al., 2011) †† Calculated using MolProbity (Chen et al., 2010).
size-exclusion chromatography at a volume consistent with a
monomer (Supplementary Fig. S2A). The oligomeric state of
BinCARD-2-124–183 was further evaluated using MALLS.
At 5 mg ml1, the elution peak of BinCARD-2-124–183
gave an average molecular weight of 13.8 kDa (Supplemen-
tary Fig. S2B), confirming that it is a monomer in solution
(theoretical molecular mass of 14.4 kDa). These results
suggest that neither BinCARD-CARD nor the soluble form
of BinCARD-2 can self-associate on their own under the
experimental conditions used.
3.2. Crystal structure of human BinCARD-CARD solved using
a double-methionine mutant
Crystals of the BinCARD-CARD construct (triclinic
symmetry, space group P1) grew from PEG-containing
conditions and diffracted to high resolution. Assuming a
solvent content of 34%, two molecules are predicted in the
asymmetric unit. We unsuccessfully attempted to solve the
structure by molecular replacement using low-sequence-
identity templates from other CARD structures (13–22%
identity to BinCARD-CARD). We then investigated multi-
wavelength anomalous diffraction (MAD) phasing using
selenomethionine. Because BinCARD-CARD has no native
methionines, we engineered first one (L66M) and then two
(F16M/L66M) methionines into the sequence to produce
F16M/L66M BinCARD-CARD. These two residues were
selected on the basis of their high degree of conservation
as hydrophobic residues (including Met) in other Bcl10-
interacting proteins. The single-mutation L66M SeMet protein
crystals did not provide sufficient phasing power to solve the
structure, but the double-mutant F16M/L66M SeMet protein
crystals did generate a solution.
The F16M/L66M SeMet protein crystals were isomorphous
to the native crystals. However, the quality of the X-ray
diffraction from the F16M/L66M SeMet crystals was highly
variable and successful phasing by MAD required the use of
a microfocus synchrotron beamline. This approach allowed
screening of different regions of the crystal to find optimal
points for measuring high-redundancy two-wavelength data
from a single F16M/L66M SeMet crystal. The combination of
the low-symmetry space group and the necessity for high-
redundancy data for MAD phasing required the measurement
of 1080 of data at both wavelengths. Using these data, the
crystal structures of SeMet F16M/L66M BinCARD-CARD
and native BinCARD-CARD were solved at resolutions of
1.40 and 1.57 A˚, respectively (Table 1). Both the native and
F16M/L66M SeMet structures of human BinCARD-CARD
revealed two monomers in the asymmetric unit, with each
monomer comprising an antiparallel six--helix bundle
(Fig. 2a).
3.3. BinCARD-CARD structures incorporate a cis-proline
The crystal structures of both the native and the double-
methionine mutant of BinCARD-CARD reveal that the
protein incorporates a cis-peptide bond between residues
Tyr39 and Pro40 in the loop connecting helices 2 and 3 (Fig. 2).
Aromatic residues, especially tryptophan and tyrosine, are
often found adjacent to prolines because they stabilize the cis
conformation through aromatic and hydrophobic interactions
(Zondlo, 2012). Moreover, cis-prolines are often associated
with protein interactions (reviewed in Kay et al., 2000) and can
undergo cis–trans isomerization to act as a timer or switch to
regulate activity (Lu et al., 2007; Schwartz et al., 2006).
We analyzed other structurally characterized CARD
proteins to identify whether cis-prolines were a common
feature of this group of proteins. However, we found no other
instance of a cis-peptide bond. A structure-based sequence
alignment of the structurally characterized CARDs (Fig. 3)
suggests that the two residues forming the cis-peptide in
BinCARD, Tyr39 and Pro40, correspond to an insertion in
the 2–3 loop of BinCARD relative to other CARDs. This
indicates that if the cis-proline is important for function then
this function is likely to be specific to BinCARD rather than to
CARD proteins more generally.
3.4. The human BinCARD-CARD crystal structure reveals
that all three cysteine residues are oxidized
An unexpected finding from the structure determination
was that all three of the cysteine residues of native BinCARD-
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Figure 2
Crystal structure of BinCARD-CARD. (a) Cartoon representation of the
BinCARD-CARD crystal structure showing the two molecules (green
and blue) in the asymmetric unit, each comprising a canonical CARD
fold of six -helices. Side chains are shown in stick format for the three
cysteines and the YP cis-peptide. (b) The boxed cis-peptide in (a) is
enlarged to show the cis-peptide bond formed between residues Tyr39
and Pro40 from the YYPQILT loop linking helices 2 and 3 in more detail.
The electron density shown corresponds to that from a 2Fo  Fc map
contoured at 1.
CARD were oxidized in both monomers of the asymmetric
unit. Thus, an intramolecular disulfide bond (right-hand hook
conformation) was formed between Cys7 and Cys77, linking
helices 1 and 5 (Fig. 4a) in both monomers. Also, additional
density at Cys63 in both molecules of the native structure
indicated oxidation, which was modelled as a cysteine sulfenic
acid (CSO; Fig. 4b). A recent analysis of protein structures
incorporating cysteines oxidized to CSO found an increased
propensity for nearby Thr or other polar residues (Salsbury et
al., 2008). These are thought to lower the pKa of the cysteine,
making it more susceptible to modification. There is a similar
preponderance of Thr residues near Cys63 of BinCARD in
that Thr18 is 4 A˚ from the Cys63 sulfur and Thr14 and Ser67
are both within 8 A˚ (Fig. 4c).
In comparison to the native BinCARD-CARD structure,
the refined F16M/L66M SeMet BinCARD-CARD crystal
structure reveals partial oxidation: the disulfide of Cys7 and
Cys77 was modelled as a mixture of both oxidized and reduced
forms. Disulfide reduction in this SeMet-labelled crystal
structure is likely to be a consequence of the long exposure to
synchrotron radiation on the insertion-device beamline which
was required to measure the high-redundancy data for MAD
phasing. Radiation-induced reduction of disulfide bonds is
often observed even in cryocooled crystals when intense third-
generation synchrotron source
radiation is used to measure
diffraction data (Garman &
Owen, 2006). There was no
evidence for the oxidation of
Cys63 to CSO in the SeMet-
labelled crystal form.
We investigated the conditions
used to generate the BinCARD-
CARD crystals to identify factors
that might contribute to cysteine
oxidation. During purification,
freshly prepared 2 mM DTT
reducing agent was included in
the dialysis and gel-filtration
buffers. This addition would be
expected to maintain the
BinCARD-CARD cysteines in
the reduced form. However, for
crystallization of native
BinCARD-CARD, a 1:1 ratio of
1 mM reduced and 1 mM
oxidized l-glutathione was
included. This ratio should also
be reducing, but if the glutathione
is stored at 277 K or room
temperature for any length of
time, the glutathione can convert
to the oxidized form (Anderson,
1985). Because the glutathione
was prepared a few days in
advance, it is possible that
cysteine oxidation of the native
form may have occurred during
crystallization as a consequence
of using this additive. On the
other hand, the F16M/L66M
SeMet BinCARD-CARD protein
was crystallized without using a
glutathione additive and retains a
disulfide bond (partially reduced
by radiation damage) between
Cys7 and Cys77. This indicates
that the Cys7–Cys77 disulfide
bond may form through air
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Figure 3
Comparison of CARDs of known structure. (a) Structure-based alignment prepared using theDALI server
(Holm & Rosenstro¨m, 2010); secondary-structure elements of the BinCARD-CARD structure are shown
above the sequences. Highly conserved hydrophobic residues are highlighted in yellow. Residues Tyr39 and
Pro40 of the cis-peptide bond are highlighted in blue. (b) Superposition of BinCARD-CARD (green) and
Apaf-1 CARD (PDB entry 1cy5; Vaughn et al., 1999; orange) showing the relative arrangement of the six
helices in both CARD structures. (c) Cartoon representation of BinCARD-CARD showing the 11 highly
conserved core hydrophobic residues in orange and the YP residues of the cis-proline in blue.
oxidation over the 5 d that it takes crystals to grow. Together,
these observations suggest that the oxidation of Cys7 and
Cys77 occurs relatively easily, whereas the oxidation of Cys63
to CSO requires a more highly oxidizing environment.
The structural data from these two crystal structures of
BinCARD-CARD, one with all three cysteines oxidized and
the other with partial oxidation of the disulfide bond, allow
analysis of the effect of cysteine oxida-
tion on the protein structure. The region
around Cys7 and Cys77 appears to be
relatively unaffected by disulfide
formation because the SeMet-labelled
crystal structure shows no major
conformational changes around these
two residues. The only apparent differ-
ence is that Cys7 becomes more acces-
sible in the reduced form. On the other
hand, comparison of the native and
SeMet-labelled crystal structures
reveals that oxidation of Cys63 to CSO
does induce a conformational change.
In both molecules in the asymmetric
unit, the side chain of Arg59 moves
away from the side chain of Cys63 in oxidized BinCARD
compared with the reduced structure. The C atom of Arg59
moves by 4 A˚ during this conformational change (Fig. 4c). The
introduced selenomethionine residues in the SeMet structure
showed no evidence of oxidation.
3.5. Comparison of BinCARD-CARD with other CARD
structures
BinCARD-CARD shares 13–22% sequence identity with
CARDs that have been structurally characterized (Table 2).
The crystal structure of NOD1 CARD is the only other
reported CARD-containing protein with oxidized cysteines.
However, the disulfide bond in NOD1 CARD is unlike that in
BinCARD-CARD. In NOD1 CARD, the two Cys39 residues
from symmetry-related monomers form a disulfide bond that
stabilizes a domain-swapped dimer structure (Srimathi et al.,
2008).
The structural homologues of BinCARD with the lowest
root-mean-square deviations (r.m.s.d.s) are NLRP1 (PDB
entry 3kat; Northeast Structural Genomics Consortium,
unpublished work) and ICEBERG (PDB entry 1dgn; Humke
et al., 2000), with r.m.s.d.s of 1.8 A˚ for 81 C atoms and 1.9 A˚
for 84 C atoms, respectively (Table 2). Despite overall low
sequence identity (19% to NLRP1 and 13% to ICEBERG),
structure-based sequence alignment revealed 11 highly
conserved hydrophobic residues across these proteins (Fig. 3).
All except Leu43 are located in helical rather than loop
regions and form a hydrophobic core (Fig. 3). This suggests
that these residues are conserved to preserve the stability of
the core CARD fold.
The lack of conserved residues on the surface of CARD
indicates that CARD-family members may have evolved
different interaction surfaces. Previous work showed that
mutation of Leu65 of BinCARD-1 to alanine abolished
its ability to bind to Bcl10 (Woo et al., 2004). Leu65 is one of
the 11 highly conserved hydrophobic core residues, suggesting
that its role may be in maintaining the CARD fold rather than
in mediating interaction with Bcl10.
BinCARD-1 and Bcl10 are thought to interact through their
CARDs, so we investigated possible CARD–CARD inter-
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Figure 4
Comparison of oxidized and reduced Cys63. (a) Cys7 and Cys77 form a
disulfide bond in the native structure. (b) Cys63 in the native structure
was modelled as a cysteine sulfenic acid (CSO) in the two molecules of
the asymmetric unit in the native structure. The electron density shown in
(a) and (b) corresponds to that from a 2Fo  Fc map contoured at 1. (c)
Cys63 is oxidized in the native structure (CSO630, modelled in two
alternate conformations; green) and not oxidized in the SeMet-labelled
structure (Cys63; white). This change in oxidation state results in
movement of the Arg59 side chain by 4 A˚ (R590 in green for the native
structure; R59 for the SeMet-labelled structure).
Table 2
Superposition of BinCARD-CARD and other CARD structures.
Resolution
(A˚) or NMR
PDB
code
R.m.s.d.†
(A˚)
Z-score†
(A˚)
Sequence
identity
(%)
No. of
aligned
residues‡ Reference
NLRP1 3.1 3kat 1.8 11.3 19 81 —
ICEBERG NMR 1dgn 1.9 11.9 13 84 Humke et al. (2000)
NOD1 2.0 2nsn 2.1 12.0 15 80 Coussens et al. (2007)
Apaf-1 1.3 1cy5 2.3 10.9 22 86 Vaughn et al. (1999)
RIG-I NMR 2lwd 2.5 7.2 21 81 Ferrage et al. (2012)
cIAP1 NMR 2l9m 2.6 9.0 17 86 Lopez et al. (2011)
Procaspase-9 2.5 3ygs 2.9 10.4 20 89 Qin et al. (1999)
MAVS 2.1 2vgq 2.9 9.0 18 87 Potter et al. (2008)
RAIDD NMR 3crd 2.9 8.4 20 87 Chou et al. (1998)
ASC NMR 2kn6 3.2 7.0 18 79 de Alba (2009)
† R.m.s.d. and Z-score were calculated using the DALI server (Holm & Rosenstro¨m, 2010). ‡ The total number of
residues in the BinCARD-CARD structure is 96.
faces of BinCARD using the crystal structure as a guide. One
classic CARD–CARD interaction is defined by the Apaf-1–
procaspase-9 complex (Qin et al., 1999; Figs. 5a and 5b). The
formation of this complex is mediated by charged surfaces on
procaspase-9 and Apaf-1 and reinforced by van der Waals and
hydrogen-bond interactions. Several residues on helices 1 and
4 of procaspase-9 form a basic patch that is complementary to
an acidic patch on Apaf-1 formed from residues located in
helices 2 and 3 (Qin et al., 1999).
There are only three basic residues on the helix 1–4 surface
of BinCARD (Arg59, Arg61 and Arg71) and these do not
form a contiguous basic surface (Fig. 5c). However, there are
three acidic residues on the helix 2–3 surface of BinCARD
(Glu25, Asp29 and Glu49) that form an acidic patch on
the surface of BinCARD-CARD (Fig. 5d). Interestingly,
BinCARD-CARD residues contributing to a region adjacent
to but not including the acidic patch are highly conserved
across all species (Fig. 5f), whereas residues contributing to
the reverse surface appear to be poorly conserved in
comparison (Fig. 5e). Overall, this suggests the possibility that
the helix 2–3 surface of BinCARD-CARD (Fig. 5f) may
interact with a complementary surface on Bcl10.
3.6. BinCARD isoforms 1 and 2 exhibit different subcellular
localization
BinCARD-1 has previously been shown to localize to nuclei
when expressed in HeLa cells and to redistribute into the
cytosol upon co-expression with Bcl10 (Woo et al., 2004).
BinCARD-2, the dominantly expressed isoform in immune
cells, has a predicted transmembrane helix C-terminal to the
CARD, indicating that it is a membrane protein. Sequence
analysis did not reveal any conserved membrane-localization
sequences (e.g. signal peptide or mitochondrial targeting
sequence), as has also been observed for other tail-anchored
proteins (Rapaport, 2003). Therefore, while we expected
BinCARD-2 to have a different distribution to the cyto-
plasmic/nuclear distribution of BinCARD-1, it was not
possible to predict which membrane it would target.
To examine the subcellular localization of human
BinCARD-2 in comparison to BinCARD-1 and to the
CARD region only (residues 1–100, designated BinCARD-N;
Supplementary Fig. S1B), we transiently expressed C-terminal
V5/His-tagged versions of the proteins in HeLa cells. Immuno-
fluorescence microscopy revealed that BinCARD-N was both
cytoplasmic and nuclear, and we confirmed the results of Woo
et al. (2004) showing that BinCARD-1 was predominantly
nuclear (Supplementary Fig. S1C). However, the distribution
pattern for BinCARD-2 was distinct from these two and
suggested localization to the endoplasmic reticulum (ER) and
mitochondria (Supplementary Fig. S1B, top panel).
Coexpression of BinCARD-2 with a well characterized ER
marker, isoprenylcysteine carboxyl methyltransferase (ICMT;
Dai et al., 1998), resulted in extensive colocalization of the two
proteins, confirming ER localization of isoform 2 (Supple-
mentary Fig. S1C, middle panel). However, co-labelling of
BinCARD-2 transfected cells for the outer mitochondrial
membrane marker Bcl-xL also revealed partial colocalization
(Supplementary Fig. S1C, bottom panel). Furthermore,
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Figure 5
Electrostatic surface features of CARD proteins. (a) Procaspase-9
CARD (PDB entry 3ygs; Qin et al., 1999) has an extensive positively
charged surface contributed by helices 1 and 4. (b) Apaf-1 CARD (PDB
entry 3ygs; Qin et al., 1999) has an extensive negatively charged surface
contributed by helices 2 and 3 on the reverse surface. (c) The equivalent
helices 1 and 4 of BinCARD-CARD do not generate a distinct positively
charged surface. (d) The electrostatic potential surface contributed by
helices 2 and 3 of BinCARD-CARD has a more limited acidic patch than
that of Apaf-1 CARD. All three structures were superimposed, so that (a)
and (c) represent equivalent surfaces of procaspase-9 and BinCARD-
CARD and (b) and (d) represent equivalent surfaces of Apaf-1 and
BinCARD-CARD. The electrostatic potential mapped onto the surface
was calculated using APBS (Baker et al., 2001) and displayed in PyMOL.
The electrostatic potential is shown over the range 10kT/e (negatively
charged) to +10kT/e (positively charged). (e, f) Sequence conservation is
shown mapped onto the surfaces of (e) helices 1 and 3 and (f) helices 2
and 3 of BinCARD-CARD shown in the same orientation as in (c) and
(d), respectively. Sequence conservation was based on a T-Coffee
multiple sequence alignment (Notredame et al., 2000; Supplementary
Fig. S3). The surface is coloured orange, light orange, yellow and white to
show residues that are identical, conserved, weakly conserved or variable,
respectively, across BinCARD-CARD sequences.
subcellular fractionation of lysates revealed enrichment of
BinCARD-2 in a Bcl-xL-enriched mitochondrial fraction.
In addition to full-length BinCARD-2, the antibody to the
C-terminal V5 tag also detected an N-terminally truncated
form in this fraction indicative of proteolytic cleavage
(Supplementary Fig. S1D). Collectively, these data demon-
strate that BinCARD-2 is dually targeted to the ER and
mitochondria.
4. Discussion
The crystal structure of native BinCARD-CARD revealed
that all three cysteines of the CARD were oxidized. Cys7 and
Cys77 form a disulfide bond in the native structure which is
partially reduced in the SeMet-labelled crystal structure,
allowing differences between the reduced and oxidized forms
to be assessed. Cys63 was also oxidized and we modelled this
as multiple conformations of cysteine sulfenic acid. If cysteine
oxidation is important for function, we would expect to
observe conservation of the cysteines in BinCARD proteins
from other organisms. Indeed, analysis of BinCARD
sequences from several organisms indicates that Cys63 is
conserved in most mammals, but not in birds, reptiles or fish.
Moreover, the cysteines Cys7 and Cys77 that form the disul-
fide are conserved in all of the BinCARDs aligned in
Supplementary Fig. S3, except for that from a fish (atlantic
salmon).
We also identified a cis-peptide bond between Tyr39 and
Pro40 in a loop comprising the sequence YYPQIL. The
tyrosine in this sequence may be important for stabilizing the
cis-proline conformation. Again, if the cis-proline is important
for function the loop sequence would be expected to be highly
conserved. The sequence alignment of BinCARD-CARDs
shows that the six-residue loop is identical except for the first
of the two tyrosines (Supplementary Fig. S3).
Although CARDs have a common fold, their sequence
identity is low, suggesting that their electrostatic surfaces,
including interacting regions, vary. CARDs often have an
asymmetric charge distribution that contributes to electro-
statically driven CARD–CARD interactions: for example, a
large basic patch on procaspase-9 interacts with a large acidic
patch on Apaf-1 to form the CARD–CARD interaction
(Qin et al., 1999; Figs. 5a and 5b). The electrostatic surface of
BinCARD-CARD does not present a basic surface like that of
procaspase-9, although a small acidic patch is present on the
equivalent surface to that found on Apaf-1. The residues
forming the acidic region in BinCARD are Glu25, Asp29 and
Glu49: Glu25 is conserved across all of the sequences analyzed
in Supplementary Fig. S3 except for that from atlantic salmon,
which instead has a threonine with an acidic residue on either
side; Asp29 is conserved in all of the sequences and Glu49
is acidic in all but two of the sequences. This suggests the
possibility that the acidic patch present on the surface of
human BinCARD-CARD may be conserved in almost all
other BinCARDs. However, a region adjacent to the acidic
patch of human BinCARD-CARD is even more highly
conserved (Fig. 5f), suggesting that this surface may contribute
the interaction interface for Bcl-10.
Many CARD-containing proteins are susceptible to
cysteine oxidation, including caspase-1 and caspase-9. For
example, the oxidation of redox-sensitive cysteines inhibits
caspase-1-mediated inflammatory processes (Meissner et al.,
2008). Cysteine oxidation of caspase-9 by mitochondrial
reactive oxygen species (ROS) is important for caspase-9
activation because it stabilizes the interaction between
caspase-9 and Apaf (Zuo et al., 2009). However, no structural
information is available for the effect of cysteine oxidation on
these CARD proteins. Whilst we cannot rule out the possi-
bility that the cysteine oxidation observed in the BinCARD
crystal structures is an artefact of protein isolation, purifica-
tion or crystallization, the conservation of the three cysteines
supports the notion that they may play an important role,
perhaps in redox regulation or sensing.
We showed that the two isoforms of human BinCARD are
differentially expressed in all immune-cell populations exam-
ined, with BinCARD-2 being the more highly expressed
isoform. The BinCARD-1 splice isoform predominantly
localizes to the nucleus, whereas BinCARD-2, the splice
isoform with a C-terminal transmembrane domain, is dually
targeted to the ER and mitochondria. Other proteins that are
dually localized to the ER and the outer membrane of mito-
chondria include several members of the Bcl-2 family of
apoptosis regulators (e.g. Bcl-2, BAX and BAK). The Bcl-2
family consists of both pro-apoptotic and anti-apoptotic
regulators that have important functions at the ER and
mitochondria during responses to cellular stress such as the
unfolded protein response (UPR), autophagy and calcium
release from the ER (Rolland & Conradt, 2010).
Many of the characteristics of BinCARD-2 are reminiscent
of another CARD protein, MAVS (also known as IPS-1, VISA
or Cardif), that like BinCARD-2 has an N-terminal CARD
and a C-terminal transmembrane domain. MAVS is also
localized to the mitochondrial outer membrane and is a critical
mediator of the viral RNA-sensing signalling pathways, which
result in downstream NFB activation (Hiscott et al., 2006).
MAVS is activated by CARD–CARD interactions with the
viral RNA-sensing protein RIG-I. This results in homo-
oligomerization of MAVS via its CARD to form large fila-
ments that are capable of activating downstream signalling.
Similarly to Bcl10, MAVS activation and signalling are
dependent on oligomerization of its CARD (Hou et al., 2011).
A cleaved form of MAVS lacking the N-terminal CARD was
also detected in mitochondrial membranes (similar to our
finding for BinCARD-2), but this form failed to be incorpo-
rated into MAVS oligomers. Removal of the transmembrane
domain of MAVS prevents its mitochondrial localization (Li et
al., 2005), as we also found for BinCARD-2. This modification
also prevents the induction of downstream signalling by
MAVS, highlighting the importance of the mitochondrial
localization for activity (Li et al., 2005).
Mitochondrial redox processes are an attractive possibility
for BinCARD-2 function, because such processes underpin
apoptosis, inter alia, a highly regulated process already asso-
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ciated with CARD–CARD interactions (Zhou et al., 1999;
Seth et al., 2005). Indeed, there are further curious parallels
with MAVS, including the activation of MAVS by mitochon-
drial ROS to trigger innate immune signalling (Arnoult et al.,
2009).
We speculate that the three modifiable cysteines of
BinCARD-2 could enable it to act as a tunable redox sensor,
whereby the presence of reactive oxygen species might first
induce disulfide formation between Cys7 and Cys77 and then
progressively oxidize Cys63 to a cysteine sulfenic acid.
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